Bethann DeGeronimo's work experience includes serving as the Director of Clinical Operations at BioXcel Therapeutics, Inc. starting in November 2022. Prior to that, they worked at Bristol Myers Squibb as a Senior Clinical Scientist/Associate Director from October 2021 to November 2022. Before joining Bristol Myers Squibb, they held positions at Allergan, where they served as an Associate Director of Clinical Development from March 2020 to October 2021, and as a Senior Clinical Scientist in Clinical Development from January 2015 to March 2020.
Bethann DeGeronimo holds a Master of Science (MS) degree in Biology from Montclair State University. No specific information regarding the start or end year of their education at Montclair State University is provided.
November, 2022 - present
Director Clinical Operations at Revolo Biotherapeutics
Director Clinical Operations at Orion Biotechnology
Director Clinical Operations at Avidity
Director Clinical Operations at Vera Therapeutics
Director Clinical Operations at Sage Therapeutics